Treanor JJ, Wilkinson BE, Masseoud F, Hu-Primmer J, Battaglia R, O'Brien D, Wolff M, Rabinovich G, Blackwelder W, Katz JM. 2001. Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans. Vaccine 19:1732–1737.
Tumpey TM, Renshaw M, Clements JD, Katz JM. 2001. Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection. J Virol 75(11):5141–5150.
Turan K, Mibayashi M, Sugiyama K, Saito S, Numajiri A, Nagata K. 2004. Nuclear MxA proteins form a complex with influenza virus NP and inhibit the transcription of the engineered influenza virus genome. Nucleic Acids Res 32:643–652.
Ulmer JB, Donnelly JJ, Parker SE, Rhodes GH, Felgner PL, Dwarki VJ, Gromkowski SH, Deck RR, DeWitt CM, Friedman A, Hawe LA, Leander KR, Martinez D, Perry HC, Shiver JW, Montgomery DL, Liu MA. 1993. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745–1749.
Ulmer JB, Fu TM, Deck RR, Friedman A, Guan L, DeWitt C, Liu X, Wang S, Liu MA, Donnelly JJ, Caulfield MJ. 1998. Protective CD4+ and CD8+ T-cells against influenza virus induced by vaccination with nucleoprotein DNA. Virology 72:5648–5653.
van Kolfschooten F. 2003. Dutch veterinarian becomes first victim of avian influenza. Lancet 361:1444.
Webster RG. 2002. The importance of animal influenza for human disease. Vaccine 20: S16–S20.
Webster RG, Askonas BA. 1980. Cross-protection and cross-reactive cytotoxic T-cells induced by influenza virus vaccines in mice. Eur J Immunol 10:396–401.
Webster RG, Kawaoka Y, Taylor J, Weinberg R, Paoletti E. 1991. Efficacy of nucleoprotein and haemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickens. Vaccine 9:303–308.
Webster RG, Sharp GB, Claas EC. 1995. Interspecies transmission of influenza viruses. Am J Respir Crit Care Med 152:S25–S30.
Wells MA, Albrecht P, Ennis FA. 1981. Recovery from a viral respiratory infection. Influenza pneumonia in normal and T deficient mice. J Immunol 126:1036–1041.
WHO (World Health Organization). 1999. Influenza Pandemic Preparedness Plan. The Role of WHO and Guidelines for National or Regional Planning. Geneva, Switzerland: WHO. [Online]. Available: http://www.who.int/csr/resources/publications/influenza/WHO_CDS_CSR_EDC_99_1/en/ [accesed December 21, 2004].
WHO. 2002. Draft WHO Guidelines on the Use of Vaccines and Antivirals during Influenza Pandemics. Issued 2-4 October 2002. Geneva, Switzerland: WHO. [Online]. Available: http://www.who.int/emc/diseases/flu/whoguidelines.html.
WHO. 2003. Preparing for the Next Influenza Season in a World Altered by SARS. Disease Outbreak #l. Severe Acute Respiratory Syndrome. Update 94 #20. 7-3-2003. [Online]. Available: http://www.who.int/csr/don/2003_07_03/en/ [accessed December 21, 2004].
Wilson TM, Logan-Henfrey L, Weller R, Kellman B. 2000. Agroterrorism, biological crimes and biological warfare targeting animal agriculture. In: Brown C, Bolin C, eds. Emerging Diseases of Animals. Washington, DC: ASM Press. Pp. 23–57.
Wilson TM, Gregg DA, King DJ, Noah DL, Perkins LE, Swayne DE, Inskeep W. 2001. Agroterrorism, biological crimes, and biowarfare targeting animal agriculture. The clinical, pathologic, diagnostic, and epidemiologic features of some important animal diseases. Clin Lab Med 21:549–591.
Wright PF, Webster RG. 2001. Orthomyxoviruses. In: Knipe DM, Howley PM, Griffin DE, eds. Fields Virology. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins. Pp. 1533–1579.
Xu X, Cox NJ, Bender CA, Regnery HL, Shaw MW. 1996. Genetic variation in neuraminidase genes of influenza A (H3N2) viruses. Virology 224:175–183.